SIGA Technologies Inc
NASDAQ:SIGA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.32
10.52
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. [ Read More ]
The intrinsic value of one SIGA stock under the Base Case scenario is hidden USD. Compared to the current market price of 9.43 USD, SIGA Technologies Inc is hidden .
Valuation Backtest
SIGA Technologies Inc
Run backtest to discover the historical profit from buying and selling SIGA based on its intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
SIGA Technologies Inc
Current Assets | 176.5m |
Cash & Short-Term Investments | 106.9m |
Receivables | 9m |
Other Current Assets | 60.6m |
Non-Current Assets | 16.2m |
PP&E | 1.5m |
Intangibles | 898.3k |
Other Non-Current Assets | 13.8m |
Current Liabilities | 21.4m |
Accounts Payable | 1m |
Accrued Liabilities | 4.3m |
Other Current Liabilities | 16m |
Non-Current Liabilities | 3.7m |
Other Non-Current Liabilities | 3.7m |
Earnings Waterfall
SIGA Technologies Inc
Revenue
|
172.9m
USD
|
Cost of Revenue
|
-31.2m
USD
|
Gross Profit
|
141.7m
USD
|
Operating Expenses
|
-38.9m
USD
|
Operating Income
|
102.7m
USD
|
Other Expenses
|
-18.8m
USD
|
Net Income
|
84m
USD
|
Free Cash Flow Analysis
SIGA Technologies Inc
USD | |
Free Cash Flow | USD |
SIGA Profitability Score
Profitability Due Diligence
SIGA Technologies Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
SIGA Technologies Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
SIGA Solvency Score
Solvency Due Diligence
SIGA Technologies Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
SIGA Technologies Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SIGA Price Targets Summary
SIGA Technologies Inc
According to Wall Street analysts, the average 1-year price target for SIGA is 17.53 USD .
Shareholder Yield
Current shareholder yield for SIGA is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
SIGA Price
SIGA Technologies Inc
Average Annual Return | 12.53% |
Standard Deviation of Annual Returns | 25.73% |
Max Drawdown | -82% |
Market Capitalization | 672.4m USD |
Shares Outstanding | 72 000 000 |
Percentage of Shares Shorted | 12.43% |
Ownership
SIGA Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company is headquartered in New York City, New York and currently employs 39 full-time employees. The Company’s lead product, TPOXX (oral TPOXX), is an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The firm does not have a manufacturing infrastructure and does not intend to develop one for the manufacture of TPOXX. The company uses contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture TPOXX. The Company’s CMOs apply methods and controls in facilities, which are uses for manufacturing, processing, packaging, testing, analyzing and holding pharmaceuticals, which conform to current good manufacturing practices (cGMP), the standard set by the FDA for manufacture and storage of pharmaceuticals intended for human use. For the manufacture of oral TPOXX, the Company uses the four CMOs, namely W.R. Grace and Company; Powdersize, LLC; Catalent Pharma Solutions LLC, and Packaging Coordinators, LLC.
Officers
The intrinsic value of one SIGA stock under the Base Case scenario is hidden USD.
Compared to the current market price of 9.43 USD, SIGA Technologies Inc is hidden .